Cargando…
Patent pools and clearinghouses in the life sciences
The biopharmaceutical industry is slowly absorbing the idea of collaborative patent licensing models. Recently, two patent pools for developing countries have been launched: the Pool for Open Innovation against Neglected Tropical Diseases initiated by GlaxoSmithKline (GSK), which is referred to as t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125884/ https://www.ncbi.nlm.nih.gov/pubmed/21733589 http://dx.doi.org/10.1016/j.tibtech.2011.06.002 |
_version_ | 1783516040187084800 |
---|---|
author | van Zimmeren, Esther Vanneste, Sven Matthijs, Gert Vanhaverbeke, Wim Van Overwalle, Geertrui |
author_facet | van Zimmeren, Esther Vanneste, Sven Matthijs, Gert Vanhaverbeke, Wim Van Overwalle, Geertrui |
author_sort | van Zimmeren, Esther |
collection | PubMed |
description | The biopharmaceutical industry is slowly absorbing the idea of collaborative patent licensing models. Recently, two patent pools for developing countries have been launched: the Pool for Open Innovation against Neglected Tropical Diseases initiated by GlaxoSmithKline (GSK), which is referred to as the BIO Ventures for Global Health (BVGH) pool, and the Medicines Patent Pool (MPP) initiated by UNITAID. Various organizations have recommended using pools or clearinghouses beyond the humanitarian dimension where many patents are owned by many different actors. As a first attempt, MPEG LA, which administers patent pools in various technology fields, is now setting up a clearinghouse for patents related to molecular diagnostics. These examples as well as the results from an empirical study provide useful insights for the design and administration of future pools and clearinghouses in the life sciences. |
format | Online Article Text |
id | pubmed-7125884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71258842020-04-08 Patent pools and clearinghouses in the life sciences van Zimmeren, Esther Vanneste, Sven Matthijs, Gert Vanhaverbeke, Wim Van Overwalle, Geertrui Trends Biotechnol Review The biopharmaceutical industry is slowly absorbing the idea of collaborative patent licensing models. Recently, two patent pools for developing countries have been launched: the Pool for Open Innovation against Neglected Tropical Diseases initiated by GlaxoSmithKline (GSK), which is referred to as the BIO Ventures for Global Health (BVGH) pool, and the Medicines Patent Pool (MPP) initiated by UNITAID. Various organizations have recommended using pools or clearinghouses beyond the humanitarian dimension where many patents are owned by many different actors. As a first attempt, MPEG LA, which administers patent pools in various technology fields, is now setting up a clearinghouse for patents related to molecular diagnostics. These examples as well as the results from an empirical study provide useful insights for the design and administration of future pools and clearinghouses in the life sciences. Elsevier Ltd. 2011-11 2011-07-04 /pmc/articles/PMC7125884/ /pubmed/21733589 http://dx.doi.org/10.1016/j.tibtech.2011.06.002 Text en Copyright © 2011 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review van Zimmeren, Esther Vanneste, Sven Matthijs, Gert Vanhaverbeke, Wim Van Overwalle, Geertrui Patent pools and clearinghouses in the life sciences |
title | Patent pools and clearinghouses in the life sciences |
title_full | Patent pools and clearinghouses in the life sciences |
title_fullStr | Patent pools and clearinghouses in the life sciences |
title_full_unstemmed | Patent pools and clearinghouses in the life sciences |
title_short | Patent pools and clearinghouses in the life sciences |
title_sort | patent pools and clearinghouses in the life sciences |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125884/ https://www.ncbi.nlm.nih.gov/pubmed/21733589 http://dx.doi.org/10.1016/j.tibtech.2011.06.002 |
work_keys_str_mv | AT vanzimmerenesther patentpoolsandclearinghousesinthelifesciences AT vannestesven patentpoolsandclearinghousesinthelifesciences AT matthijsgert patentpoolsandclearinghousesinthelifesciences AT vanhaverbekewim patentpoolsandclearinghousesinthelifesciences AT vanoverwallegeertrui patentpoolsandclearinghousesinthelifesciences |